ORG Wealth Partners’s Fulgent Genetics FLGT Stock Holding History

ORG Wealth Partners’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$396	Buy	+18	New	+$362	﹤0.01%	2152

Other funds holding FLGT

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

ORG Wealth Partners's FLGT Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Fulgent Genetics (FLGT) in Q3 2026: 18 shares worth $396. The stake represents ﹤0.01% of the portfolio and ranks #2152 among its holdings.

84 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

ORG Wealth Partners held 18 shares of Fulgent Genetics worth $396 as of Q3 2026.
Fulgent Genetics was a new ORG Wealth Partners position in Q3 2026.
Fulgent Genetics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2152 holding.
84 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.